Prescriptions for antipsychotics in general practice

Christopher M Harrison and Helena C Britt
Med J Aust 2003; 178 (9): . || doi: 10.5694/j.1326-5377.2003.tb05296.x
Published online: 5 May 2003

To the Editor: At the Australasian Schizophrenia Conference in Sydney in October 2002, Professor Patrick McGorry of the Orygen Research Centre, University of Melbourne, presented draft guidelines on the management of schizophrenia and early psychoses.1 One of the recommendations was that atypical antipsychotic drugs should be used as the first-line pharmacological treatment in preference to typical antipsychotics and depot antipsychotics. With a shift in management of schizophrenia to community-based care, the number of patients with schizophrenia managed by general practitioners has increased over the past decade (from 36 per 10 000 encounters in 1990–91 to 45 per 10 000 in 2000–02).2 With the pending introduction of the guidelines, a baseline measure of GP prescribing rates of antipsychotics, both typical and atypical, will allow future measurement of the impact of the guidelines.

  • Christopher M Harrison
  • Helena C Britt



Thanks to the Commonwealth Department of Health and Ageing, AstraZeneca Pty Ltd (Australia), Aventis Pharma Pty Ltd, Janssen–Cilag Pty Ltd and Roche Products Pty Ltd for funding; to the GP participants; and Stephanie Knox, for assistance with statistical analysis.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.